TNFRSF9 and cancer: Despite the intrinsic limitations of mouse-based toxicology studies in resembling the toxic effects of many drugs in humans, it is important to underscore that they recapitulate well the immune-related adverse events (irAEs) observed with various drugs used in cancer immunotherapy such as the anti-4-1BB agonistic antibody.50